Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Pseudomonas aeruginosa small protease (PASP), a keratitis virulence factor.

Tang A, Caballero AR, Marquart ME, O'Callaghan RJ.

Invest Ophthalmol Vis Sci. 2013 Apr 17;54(4):2821-8. doi: 10.1167/iovs.13-11788.

2.

Molecular tracing of the emergence, adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureus.

McAdam PR, Templeton KE, Edwards GF, Holden MT, Feil EJ, Aanensen DM, Bargawi HJ, Spratt BG, Bentley SD, Parkhill J, Enright MC, Holmes A, Girvan EK, Godfrey PA, Feldgarden M, Kearns AM, Rambaut A, Robinson DA, Fitzgerald JR.

Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):9107-12. doi: 10.1073/pnas.1202869109.

3.

Childhood microbial keratitis.

Al Otaibi AG, Allam K, Damri AJ, Shamri AA, Kalantan H, Mousa A.

Oman J Ophthalmol. 2012 Jan;5(1):28-31. doi: 10.4103/0974-620X.94763.

5.

Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis.

Lalitha P, Srinivasan M, Manikandan P, Bharathi MJ, Rajaraman R, Ravindran M, Cevallos V, Oldenburg CE, Ray KJ, Toutain-Kidd CM, Glidden DV, Zegans ME, McLeod SD, Acharya NR, Lietman TM.

Clin Infect Dis. 2012 May;54(10):1381-7. doi: 10.1093/cid/cis189.

6.

A metalloproteinase secreted by Streptococcus pneumoniae removes membrane mucin MUC16 from the epithelial glycocalyx barrier.

Govindarajan B, Menon BB, Spurr-Michaud S, Rastogi K, Gilmore MS, Argüeso P, Gipson IK.

PLoS One. 2012;7(3):e32418. doi: 10.1371/journal.pone.0032418.

7.

Staphylococcus aureus α-hemolysin mediates virulence in a murine model of severe pneumonia through activation of the NLRP3 inflammasome.

Kebaier C, Chamberland RR, Allen IC, Gao X, Broglie PM, Hall JD, Jania C, Doerschuk CM, Tilley SL, Duncan JA.

J Infect Dis. 2012 Mar 1;205(5):807-17. doi: 10.1093/infdis/jir846.

8.

Traversal of multilayered corneal epithelia by cytotoxic Pseudomonas aeruginosa requires the phospholipase domain of exoU.

Ramirez JC, Fleiszig SM, Sullivan AB, Tam C, Borazjani R, Evans DJ.

Invest Ophthalmol Vis Sci. 2012 Jan 25;53(1):448-53. doi: 10.1167/iovs.11-8999.

9.

Identification and potency of cyclodextrin-lipid inhibitors of Staphylococcus aureus α-toxin.

Weeks AC, Balzli CL, Caballero A, Tang A, O'Callaghan R.

Curr Eye Res. 2012 Feb;37(2):87-93. doi: 10.3109/02713683.2011.624669.

PMID:
22050601
10.

Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae Keratitis.

Norcross EW, Sanders ME, Moore QC 3rd, Taylor SD, Tullos NA, Caston RR, Dixon SN, Nahm MH, Burton RL, Thompson H, McDaniel LS, Marquart ME.

Invest Ophthalmol Vis Sci. 2011 Nov 29;52(12):9232-43. doi: 10.1167/iovs.10-6968.

11.

Crystal structure of the octameric pore of staphylococcal γ-hemolysin reveals the β-barrel pore formation mechanism by two components.

Yamashita K, Kawai Y, Tanaka Y, Hirano N, Kaneko J, Tomita N, Ohta M, Kamio Y, Yao M, Tanaka I.

Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17314-9. doi: 10.1073/pnas.1110402108.

12.

Characterization of protease IV expression in Pseudomonas aeruginosa clinical isolates.

Conibear TC, Willcox MD, Flanagan JL, Zhu H.

J Med Microbiol. 2012 Feb;61(Pt 2):180-90. doi: 10.1099/jmm.0.034561-0.

PMID:
21921113
13.

Ophthalmic antibiotic use and multidrug-resistant staphylococcus epidermidis: a controlled, longitudinal study.

Dave SB, Toma HS, Kim SJ.

Ophthalmology. 2011 Oct;118(10):2035-40. doi: 10.1016/j.ophtha.2011.03.017.

PMID:
21856006
14.
15.

Antibiotic resistance in microbial keratitis: ten-year experience of corneal scrapes in the United Kingdom.

Shalchi Z, Gurbaxani A, Baker M, Nash J.

Ophthalmology. 2011 Nov;118(11):2161-5. doi: 10.1016/j.ophtha.2011.04.021.

PMID:
21764458
16.

Pediatric ocular surface infections: a 5-year review of demographics, clinical features, risk factors, microbiological results, and treatment.

Wong VW, Lai TY, Chi SC, Lam DS.

Cornea. 2011 Sep;30(9):995-1002. doi: 10.1097/ICO.0b013e31820770f4.

PMID:
21705879
17.

Molecular genetic investigations of contaminated contact lens storage cases as reservoirs of Pseudomonas aeruginosa keratitis.

Ogushi Y, Eguchi H, Kuwahara T, Hayabuchi N, Kawabata M.

Jpn J Ophthalmol. 2010 Nov;54(6):550-4. doi: 10.1007/s10384-010-0874-1.

PMID:
21191715
18.

Moxifloxacin and cholesterol combined treatment of pneumococcal keratitis.

Sanders ME, Tullos NA, Taylor SD, Norcross EW, King LB, Tolo I, Marquart ME.

Curr Eye Res. 2010 Dec;35(12):1142-7. doi: 10.3109/02713683.2010.512114.

19.

Cooperation between LepA and PlcH contributes to the in vivo virulence and growth of Pseudomonas aeruginosa in mice.

Kida Y, Shimizu T, Kuwano K.

Infect Immun. 2011 Jan;79(1):211-9. doi: 10.1128/IAI.01053-10.

20.

Etiology and antibacterial susceptibility pattern of community-acquired bacterial ocular infections in a tertiary eye care hospital in south India.

Bharathi MJ, Ramakrishnan R, Shivakumar C, Meenakshi R, Lionalraj D.

Indian J Ophthalmol. 2010 Nov-Dec;58(6):497-507. doi: 10.4103/0301-4738.71678.

Items per page

Supplemental Content

Support Center